CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Clinical Trials
Original article

Nitinotes Announces Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center Clinical Site Activation in the EASE™ IDE Trial

Trial StartEndoZip™ Automated Suturing SystemPositive
AI Analysis

Summary

Nitinotes announced activation of a clinical site at Weill Cornell Medicine for the EASE™ IDE Trial, with the first patient treated for the EndoZip™ Automated Suturing System used in Endoscopic Sleeve Gastroplasty.

Clinical Trial Data

Patients

1

Outcome Details

First study patient treated at clinical site

Importance:4/10
Sentiment:
0.30
clinical trialsite activationmedical deviceendoscopyweight lossIDE trial
Related Companies

Read the original article

Published by PR Newswire Clinical Trials on August 11, 2026 1:30 PM

Read Original